• 제목/요약/키워드: Intermediate treatment

검색결과 522건 처리시간 0.027초

농촌지역의 건설폐기물 중간처리 사업장 주변 환경 영향 평가 및 개선방안 연구 (A Study on Environmental Impact Assessment and Improvement Measures Around Construction Waste Intermediate Processing Sites in Rural Areas)

  • 장경필;김병윤
    • 한국농촌건축학회논문집
    • /
    • 제26권2호
    • /
    • pp.65-72
    • /
    • 2024
  • In order to analyze the impact of fine dust generated from a construction waste intermediate processing site on the surrounding areas, diverse types of samples were collected from inside the site and surrounding areas. The impact analysis results of samples are as follows. (1) Compared to the air quality management standards by the Ministry of Environment, the concentration of fine dust within the site was 30 to 46% for PM10 and 14 to 42% for PM2.5, which was not much different from the general air quality level. (2) It was found that PM10 within the site may have a partial effect on the air quality, but when the blocking facilities in the site, wheel washing facilities at vehicle entry and exit route, and sprinkler during working were maintained, the impact on the nearby area was not high. (3) In the case of PM2.5, its concentration was influenced more by the exhaust fumes from work vehicles than fine dust generated during construction waste processing. Since the PM2.5 concentrations in the site and surrounding area were not much different from the general air quality, there was little correlation with the work impact of construction waste intermediate processing sites. (4) Pb, an indicator of heavy metal components, was within 50ng/m3 in all three sites, which was 10% of the domestic management standard and equivalent to the general air quality level. The complaints from residents in nearby areas were filed using indicators based on visual and experiential information in their daily lives, so even if the survey results of environmental impact by the construction intermediate waste processing site are lower than the standard, nearby residents can feel it better than such numerical information. Therefore, specific activities to reduce find dusts should be continuously continued.

치과용 금합금의 표면처리에 따른 교정용 브라켓의 전단결합강도 변화 (Change of shear bond strength of orthodontic brackets according to surface treatment on dental gold alloy)

  • 민지현;황현식;김종철
    • 대한치과교정학회지
    • /
    • 제30권4호
    • /
    • pp.483-490
    • /
    • 2000
  • 치과용 금합금에 브라켓을 부착하는 경우 자연치에 비하여 낮은 결합강도를 보이며, 잦은 브라켓 탈락이 나타나고 있는 바, 본 연구는 여러 가지 금합금 표면처리 방법이 교정용 레진 접착제와 금합금 간의 전단결합강도에 미치는 영향을 평가하여 금합금과 브라켓 간의 부착강도 증진방법을 모색하고자 시행하였다. 치과용 금합금으로 주조된 240개의 시편을 표면처리 유무 및 방법에 따라 무처리, 샌드블라스팅 단독처리, 샌드블라스팅과 주석도금 병용처리, 그리고 샌드블라스팅과 중간접착제 병용처리의 4가지 경우와, Ortho-one, Panavia 21, Superbond C&B의 3가지 레진접착제의 조합에 의해 12군으로 나누어 브라켓을 부착하였다. 시편을 증류수에 담아 $37^{\circ}C$ 항온 수조 속에서 24시간 동안 보관한 후, 만능물성 시험기를 이용하여 전단결합강도를 측정한 후 다음과 같은 결과를 얻었다. 1. 치과용 금합금의 표면을 처리하지 않은 경우에 비하여 표면처리한 군에서 통계적으로 유의하게 높은 전단결합강도가 나타났다. 2. 샌드블라스팅 단독처리에 비하여 주석도금 병용처리를 시행한 경우 Panavia 21에서만 유의한 결합강도 증가가 나타났다. 3. 샌드블라스팅 단독처리에 비하여 중간접착제 병용처리를 시행한 경우 모든 접착제에서 유의한 결합강도 증가가 나타났다. 4. 사용된 레진접착제에 따른 전단결합강도를 비교한 결과 Superbond C&B가 가장 높고 그 다음으로 Panavia 21, Ortho-one 순으로 나타나는 양상을 보였다. 이상의 결과는 금합금 표면에서 브라켓 부착강도를 증가시키기 위해서는 레진접착제 종류에 관계없이 샌드블라스팅과 중간접착제 병용처리가 필요함을 시사하였다.

  • PDF

I, II기 Intermediate Grade 임파종에서 방사선 치료의 역할 (The Role of Radiotherapy in Stage I , II Intermediate Grade Non-Hodgkin's Lymphoma)

  • 윤형근;김일한;김흥태;안용찬;김재성;하성환;박찬일
    • Radiation Oncology Journal
    • /
    • 제9권1호
    • /
    • pp.103-109
    • /
    • 1991
  • I, II기 intermediate grade악성 임파종에서 방사선 치료의 역할을 극인하기 위하여 서울대학교 병원 치료 방사선과에서 치료받은 162예의 방사선 치료 성적을 분석하였다. 초기의 치료 실패 양상 이 확인 가능한 68 예 중 38.2%는 조사야 내에서 61.8%는 조사야 밖에서 치료 실패 또는 재발 하였다. I기에서는 조사야 내 및 외에서 발생한 치료 실패 양상은 국소 조사야 치료시 각각 30.0%와 70.0%였고, 확대 조사야 치료시는 각각 43.8% 와 56.2%였다. II기에서는 각각 16.7% 와 83.3% 및 41.7%와 58.3%였다. 5년 무병 생존율은 전 환자에서 48.1%였고, I기 및 II기에서 각각 56.3%와 40.4%로 병기에 따른 유의한 차이가 있었다. 10cm 이상의 종괴나 전신적 증상은 무병 생존율에 영향을 미치지 못하였다. 방사선 치료 범위가 큰 경우에 5년 무병 생존율이 양호하였고 특히 I기에서는 유의하였다. 재발후에 시행한 전신 화학요법의 효과를 감안한 5년 생존율은 I, II기에서 각각 65.3% 및 52.2%였으며 병기에 따른 유의한 차이는 없었다. 따라서 5년 무병 생존율을 향상시키기 위해서는 원발 병소와 인접한 임파절 부위를 포함하는 화대 조사야로 치료할 필요가 있으며 재발된 경우에는 전신 화학 요법이 유용할 것으로 시사된다.

  • PDF

갑상선의 $H\"{u}rthle$씨 세포 종양 ($H\"{u}rthle$ Cell Tumor of the Thyroid)

  • 정웅윤;김석주;박정수
    • 대한두경부종양학회지
    • /
    • 제13권2호
    • /
    • pp.206-212
    • /
    • 1997
  • H$\"{u}$rthle cell neoplasm of the thyroid gland is an uncommon, but potentially malignant lesion. However, in many instances, the malignant potential of the H$\"{u}$rthle cell neoplasm is very difficult to judge histologically. For this reason, the biologic behavior of this tumor and its optimal treatment have come under considerable debate in recent years. In order to review the clinicopathologic features of the H$\"{u}$rthle cell neoplasm and to determine its optimal treatment modalities, we studied 26 patients with path logical proof of H$\"{u}$rthle cell tumor from January 1987 to September 1997. We also performed an immunohistochemical study using the monoclonal antibodies against antigen CD34 for the angiogenic activity of this tumor and evaluated the differences of microvessel density(MVD) between benign and malignant tumors. The age of the patients ranged from 1 to 71 years with a mean of 44.2 years. There were 6 males and 20 females(M : F= 1 : 3.3). The accuracies of fine needle aspiration biopsy and frozen section were very low; 6.3% and 34.8%, respectively. There were 20 benign tumors and 6 malignant tumors(23.1%). All the malignant tumors were microinvasive(intermediate) type which had minimal capsular invasion and most of them(5 cases) were diagnosed postoperatively. Any specific clinicopathologic differences were not seen between benign and intermediate groups. Most of the cases had conservative surgeries(15 ipsilateral lobectomy-isthmusectomy, 7 subtotal thyroidectomy) while total thyroidectomy was performed in 4 cases. Of the cases with malignant tumor, 2 had ipsilateral lobectomy-isthmusectomy, 3 had subtotal thyroidectomy and the remaining 1 had total thyroidectomy. Mean size of the tumors was 3.0 cm(0.1- 8.5 cm) in the greatest diameter and multiple tumors were seen in 6 cases(23.1 %). During the follow-up period, only one recurrence(3.8%) of benign tumor occurred but distant metastasis or cause-specific death was seen in the benign or intermediate groups. Mean MVDs of the benign(n=13) and intermediate(n=6) groups were $121.7{\pm}35.3$ and $114.3{\pm}31.7$, respectively and there was no statistical significance between them. In conclusion, because of the low accuracies of fine needle aspiration biopsy and frozen section for the H$\"{u}$rthle cell neoplasm, the extent of surgery could be individualized based on permanent pathologic examination; Conservative surgery would be adequate for patients with benign or intermediate H$\"{u}$rthle cell neoplasm and total or near-total thyroidectomy for those with definite malignancy.

  • PDF

Long Term Outcomes of Patients with Endometrial Carcinoma Treated with Radiation - Siriraj Hospital Experience

  • Setakornnukul, Jiraporn;Petsuksiri, Janjira;Wanglikitkoon, Sirentra;Warnnissorn, Malee;Thephamongkhol, Kullathorn;Chansilp, Yaowalak;Veerasarn, Vutisiri
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권5호
    • /
    • pp.2279-2285
    • /
    • 2014
  • Background: To evaluate treatment outcomes of patients with stage I-III endometrial cancer treated with postoperative radiation. Materials and Methods: A retrospective review of 166 endometrial cancer patients, undergoing surgery and postoperative radiotherapy at Siriraj Hospital from 2005-2008 was performed. Pathology was reviewed. Results of treatment were reported with 5-year loco-regional recurrence free survival (LRRFS), 5-year overall survival (OS), patterns of failure and toxicity, and according to stage and risk groups. Results: Median follow up time was 62.8 months. Pathological changes were found in 36.3% of the patients after central reviews, leading to 19% changes in risk groups. Most of the patients (83.7%) received pelvic radiation (PRT) and vaginal brachytherapy (VBT). Five-year LRRFS and OS of all patients were 94.9% and 85.5%, respectively. There was no recurrence or death in low and low-intermediate risk groups. For the high-intermediate risk group, 5-year LRRFS and OS were 96.2% and 90.8%, respectively, and for the high risk group 90.5% and 71%. Late grade 3 and 5 gastrointestinal toxicity was found in 3% and 1.2% of patients, respectively. All of them received PRT 5,000 cGy in 25 fractions. Conclusions: Low and intermediate risk patients had good results with surgery and adjuvant radiation therapy. For high risk patients, postoperative radiation therapy alone appeared to be inadequate as the most common pattern of failure was distant metastasis.

Intensity-modulated Radiotherapy Combined with Endocrine Therapy for Intermediate and Advanced Prostate Cancer: Long-term Outcome of Chinese Patients

  • Luo, Hua-Chun;Cheng, Hui-Hua;Lin, Gui-Shan;Fu, Zhi-Chao;Li, Dong-Shi
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권8호
    • /
    • pp.4711-4715
    • /
    • 2013
  • Aim: The aim of this study was to evaluate acute adverse events and efficacy of three-dimensional intensitymodulated radiotherapy (IMRT) combined with endocrine therapy for intermediate and advanced prostate cancer. Methods: Sixty-seven patients were treated with three-dimensional IMRT combined with maximum androgen blockade. The correlation between radiation-induced rectal injury and clinical factors was further analyzed. Results: After treatment, 21 patients had complete remission (CR), 37 had partial remission (PR), and nine had stable disease (SD), with an overall response rate of 86.5%. The follow-up period ranged from 12.5 to 99.6 months. Thirty-nine patients had a follow-up time of ${\geq}$ five years. In this group, three-year and five-year overall survival rates were 89% and 89.5%, respectively; three-year and five-year progression-free survival rates were 72% and 63%. In univariate analyses, gross tumor volume was found to be prognostic for survival ($X^2$ = 5.70, P = 0.037). Rates of leucopenia and anemia were 91.1% and 89.5%, respectively. Two patients developed acute liver injury, and a majority of patients developed acute radiation proctitis and cystitis, mainly grade 1/2. Tumor volume before treatment was the only prognostic factor influencing the severity of acute radiation proctitis (P < 0.05). Conclusions: IMRT combined with endocrine therapy demonstrated promising efficacy and was well tolerated in patients with intermediate and advanced prostate cancer.

창이초(蒼耳草)의 약용부위별(藥用部位別) 추출물이 항감염(抗感炎) 및 항종양(抗腫瘍) 면역반응(免疫反應)에 미치는 영향 (Effects of Herba, Radix, Fructus-xanthii Extract on the Immunities against infections Diseases and Tumors)

  • 조남준;송호준;신민교
    • 대한한의학회지
    • /
    • 제19권2호
    • /
    • pp.420-438
    • /
    • 1998
  • Herba Xanthii(HX), Radix Xantluii(RX) and Fructus Xanthii(FX) is one of the oriental medicine that has been used for the treatment of such infectious diseases and tumors. However, the mechanism of the drug is not investigated much. This study was done to know the effects of HX, RX and FX extract on the such innate immunities as phagocytic function and reactive radical formtions from phagocytes and the such acquired immunities as humoral and cell-mediated immunities. The followings are the results obtained from this study: 1. HX2 and FX1 groups increases the in vivo phagocytic activity of mononuclear phagocytes. 2. HXB, RXB, RXC, FXB and FXC groups increase the in vitro phagocytic activities. 3. RXB group stimulated the macrophages to produce nitric oxide in the presence of $interferon-{\gamma}$ $(IFN-{\gamma})$. 4. HX and RX whole groups increased the luminol-amplified reactive oxygen intermediate production in vivo. 5. HX whole and RX1, FX2 groups increased the lucigenin-amplified reactive oxygen intennediate production in vivo. 6. HXC group only increased the luminol-amplified reactive oxygen intermediate production in vitro. 7. HXB, FXB and FXC groups increased the lucigenin-amplified reactive oxygen intermediate production in vitro. 8. HX2, RX1 and FX whole groups increased the hemolysin formations from B cells. 9. HX, RX and FX whole groups significantly increased the rosette forming cells from the spleen. 10. HX, RX and FX whole groups significantly decreased the delayed-type hypersensitivity measured by footpad swelling. The above results demonstrate that HX, RX and FX has enhancing effects on innate immunity selectively and decreasing effects on delayed-type hypersensitivity of cell-mediated immunity according to medicinal part and diluted condition. This immunomodulating effects of HX, RX and FX might be responsible for the treatment of immune-mediated disorders.

  • PDF

외측 거골 골연골 병변에 대한 자가 골연골 이식술 후의 중기 추시 임상결과 (Intermediate-Term Clinical Outcomes after Autologous Osteochondral Transplantation for Lateral Osteochondral Lesions of the Talus)

  • 김성후;조병기
    • 대한족부족관절학회지
    • /
    • 제27권4호
    • /
    • pp.137-143
    • /
    • 2023
  • Purpose: Autologous osteochondral transplantation (AOT) is indicated for patients with a large osteochondral lesion of the talus (OLT), accompanying subchondral cyst, and the failure of bone marrow stimulation (BMS) procedures. Despite the many reports on the clinical results of surgical treatment for medial osteochondral lesions, those of lateral lesions are rare. This paper reports the intermediate-term clinical outcomes after AOT for lateral OLTs. Materials and Methods: Twenty-one patients with lateral OLTs were followed up for at least three years after AOT. The clinical evaluations comprised the Foot and Ankle Outcome Score (FAOS) and Foot and Ankle Ability Measure (FAAM). The radiographic assessment included the irregularity of the articular surface (subchondral plate), the progression of degenerative arthritis, and the changes in talar tilt angle and anterior talar translation. Results: The mean FAOS and FAAM scores improved significantly from 42.1 to 89.5 and 39.5 to 90.6 points, respectively, at the final follow-up (p<0.001). The radiological evaluation revealed two cases (9.5%) of articular step-off ≥2 mm and 1 case (4.8%) of progressive arthritis. The mean talar tilt angle and anterior talar translation improved significantly. As postoperative complications, there was one case of a local wound problem, one case of superficial peroneal nerve injury, and one case of donor site morbidity. At a mean follow-up of 62.3 months, no patient showed a recurrence of instability or required reoperation for OLT. Conclusion: AOT for the lateral OLTs demonstrated satisfactory intermediate-term clinical outcomes, including daily and sports activity abilities. Most OLT could be accessed through lateral ligament division and capsulotomy, and the incidence of iatrogenic complications, such as recurrent sprains or chronic instability, was minimal. AOT appears to be an effective and relatively safe treatment for patients with large lateral osteochondral lesions unresponsive to conservative therapy, with subchondral cysts, or with failed primary BMS.